One notable observation was that in addition to anti-tumour activity, the application of anti-CTLA-4 antibodies established a specific protective memory response against the tumour following treatment with anti-CTLA-4 antibodies, opening the possibility of a post-tumour vaccination effect [49, 50, 53]. This evidence concerns the gene CTLA4 and neoplasm.